Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model

Pancreas

Volumn 35, Issue 4, 2007, Pages

  Novelli, Michela ^a   D’aleo, Valentina ^a   Lupi, Roberto ^a   Paolini, Moreno ^b   Soleti, Antonio ^c   Marchetti, Piero ^a   Masiello, Pellegrino ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Medestea Research   (Italy)

Author keywords

Antioxidant treatment; Mouse; Nitrotyrosine; Oxidative stress; Pancreatic insulin content; Type 2 diabetes

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; BIS(1 HYDROXY 2,2,6,6 TETRAMETHYLMETHYL 4 PIPERIDINYL)DECANDIOATE; GLUCOSE; INSULIN; NICOTINAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERGLYCEMIA; HYPOINSULINEMIA; INSULINEMIA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTERS; FATTY ACIDS, NONESTERIFIED; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; NIACINAMIDE; OXIDATIVE STRESS; PANCREAS; PIPERIDINES; STREPTOZOCIN; TIME FACTORS; TYROSINE;

EID: 37349061994     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/mpa.0b013e318150e4f2     Document Type: Article

References (42)

1. Kahn SE. The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003;46:3-19.
2. Matthews DR, Cull CA, Stratton IM, et al. UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabetes Med. 1998;15:297-303.
3. Kahn SE. The importance of β-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab. 2001;86:4047-4058.
4. Kaneto H, Kawamori D, Matsuoka T, et al. Oxidative stress and pancreatic β-cell dysfunction. Am J Ther. 2005;12:529-533.
5. Prentki M, Nolan CJ. Islet β cell failure in type 2 diabetes. J Clin Invest. 2004;116:1802-1812.
6. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257-267.
7. Nishikawa T, Edelstein D, Du X-L, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787-790.
8. Brownlee M. A radical explanation for glucose-induced β cell dysfunction. J Clin Invest. 2003;112:1788-1790.
9. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307:384-387.
10. Kaneto H, Fujii J, Myint T, et al. Reducing sugars trigger oxidative modification and apoptosis in pancreatic β-cells by provoking oxidative stress through the glycation reaction. Biochem J. 1996;320:855-863.
11. Kaneto H, Xu G, Song KH, et al. Activation of the hexosamine pathway leads to deterioration of pancreatic β-cell function by provoking oxidative stress. J Biol Chem. 2001;276:31099-31104.
12. Garcia Soriano F, Viràg L, Szabo C. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation. J Mol Med. 2001;79:437-448.
13. Davì G, Falco A, Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal. 2005;7:256-268.
14. Spitaler MM, Graier WF. Vascular targets of redox signalling in diabetes mellitus. Diabetologia. 2002;45:476-494.
15. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424-C1437.
16. Sakuraba H, Mizukami H, Yagihashi N, et al. Reduced β-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia. 2002;45:85-96.
17. Butler AE, Janson J, Bonner-Weir S, et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102-110.
18. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet β cells in diabetes. J Biol Chem. 2004;279:42351-42354.
19. Tiedge M, Lortz S, Drinkgern J, et al. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes. 1997;46:1733-1742.
20. Marchioli R, Schweiger C, Levantesi G, et al. Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids. 2001;36:S53-S63.
21. Cuzzocrea S, Riley DP, Caputi AP, et al. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001;53:135-159.
22. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care. 2003;26:1589-1596.
23. Nakamura T, Terajima T, Ogata T, et al. Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide. Biol Pharm Bull. 2006;29:1167-1174.
24. Valgimigli L, Pedulli GF, Paolini M. Measurement of oxidative stress by EPR radical-probe technique. Free Radic Biol Med. 2001;31:708-716.
25. Paolini M, Valgimigli L, Marchesi E, et al. Taking EPR "snapshots" of the oxidative status in human blood. Free Radic Res. 2003;37:503-508.
26. Del Guerra S, Grupillo M, Masini M, et al. Gliclazide protects human islet β-cells from apoptosis induced by intermittent high glucose. Diabetes Metab Res Rev. 2007;23:234-238.
27. Masiello P, Broca C, Gross R, et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998;47:224-229.
28. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 1998;356:1-11.
29. Ceriello A, Mercuri F, Quagliaro L, et al. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia. 200;144:834-838.
30. Novelli M, Fabregat ME, Fernandez-Alvarez J, et al. Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes. Mol Cell Endocrinol. 2001;175:57-66.
31. Tanaka Y, Gleason CE, Tran PO, et al. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A. 1999;96:10857-10862.
32. Kaneto H, Kajimoto Y, Miyagawa J, et al. Beneficial effects of antioxidants in diabetes. Possible protection of pancreatic β-cells against glucose toxicity. Diabetes. 1999;48:2398-2406.
33. Gorogawa S, Kajimoto Y, Umayahara Y, et al. Probucol preserves pancreatic β-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res Clin Pract. 2002;57:1-10.
34. Kawamori D, Kajimoto Y, Kaneto H, et al. Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun N-terminal kinase. Diabetes. 2003;52:2896-2904.
35. Lupi R, Del Guerra S, Mancarella R, et al. Insulin secretion defects of human type 2 diabetic islets are corrected by preculture with a new reactive oxygen species scavenger. Diabetes Metab. 2007 July 6. "Epub ahead of print".
36. Marchetti P, Del Guerra S, Marselli L, et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab. 2004;89:5535-5541.
37. Vanella A, Russo A, Acquaviva R, et al. l-Propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol. 2000;16:99-104.
38. Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition. 2001;17:888-895.
39. Szabo C, Mabley JG, Moeller SM, et al. Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol Med. 2002;8:571-580.
40. Nassar T, Kadery B, Lotan C, et al. Effects of the superoxide dismutase mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2002;436:111-118.
41. Felix C, Gillis M, Driedzic WR, et al. Effects of propionyl-l-carnitine on isolated mitochondrial function in the reperfused diabetic rat heart. Diabetes Res Clin Pract. 2001;53:17-24.
42. Coppey LJ, Gellett JS, Davidson EP, et al. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes. 2001;50:1927-1937.